FDA Cracking Down on Fake Diabetes/Weight Loss Drugs in Warning Letters

Two online marketers of semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro) received FDA warning letters for selling the unapproved, untested drugs to consumers through their websites.
Source: Drug Industry Daily